Ou Jian cooperates with Heidelberg University in Germany to carry out peptide and cell therapy efficacy research

Frankfurt, Germany, October 28, 2021/PRNewswire/ - European Wellness Academy ("EWA"), the educational branch of European Wellness Biomedical Group ("EWG"), has signed an agreement An agreement to conduct joint scientific research on the rejuvenation efficacy of peptides, cell therapy, exosomes, and cell reprogramming in a mouse model of progeria

Representatives of Oujian College, Professor Gecheng Chen, Chairman of the Group, Katrin Erk, Managing Director of Business at Heidelberg University, and Professor/Dr

Cutting-edge therapies used in research include precursor (progenitor) stem cells, precursor cells (Frozen Organo Crygenics), Mito Organelle, nanopeptides, and exosomes

Their research includes in vitro experiments, focusing on the product's effects on somatic cell senescence and cellular senescence, and cellular senescence can cause disease to occur and worsen

The European Health Institute and Heidelberg University will also conduct in vivo experiments to prove the safety and efficacy of the therapy.

Other criteria include cartilage/joint/bone regeneration, including knee/joint/hip, neck, chest, lumbar, pelvic and musculoskeletal diseases, and endocrine disorders, such as endocrine dysfunction and sleep caused by excessive or insufficient hormone secretion- Other activity patterns during the awakening cycle

The ongoing research is meticulously designed and coordinated by Professor Thomas Skutella/Ph.

About Oujian Academy

Located in Germany, Switzerland, Greece and Malaysia, Oujian Academy is an institution authorized by the British CPD.